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were evaluated.
Results: The site of aneurysm was splenic artery in
16 patients and common hepatic artery in 3 patients,
while the remaining two patients had gastroduodenal
and celiac aneurysms, respectively. All the lesions were
asymptomatic and the mean diameter was 23.9 mm.
Interventions consisted in coil embolization in 14 cases;
in four patients a covered stent was placed, while the
remaining three patients had a multilayer stent. Technical
success was 91%. There were no perioperative deaths; one
patient with splenic artery aneurysm had coils migration
with symptomatic splenic infarction and underwent
successful redo embolization. Median duration of
follow-up was 20 months. During follow-up one aneu-
rysm-unrelated death occurred. Neither thrombosis of
the treated artery nor reintervention were recorded.
Mean aneurismal diameter at the latest follow-up was
20.2 mm (P ¼ .001 in comparison with preoperative
values; 95% CI, 1.7-5.5). Complete exclusion of the aneu-
rysm occurred in all but one patient, who had a limited
increasing in the diameter of its splenic aneurismal sac
after coil embolization. Another patient developed
a more distal aneurysm of the splenic artery after 24
months. Freedom from aneurysm-related complications
at 2 years was 70% (SE 0.10).
Conclusions: In our experience, endovascular treat-
ment of visceral artery aneurysm is feasible with low perio-
perative morbidity. Follow-up results are satisfactory;
however the risk of developing aneurysm-related complica-
tions warrants the need for prolonged surveillance.
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Clinical Outcomes After Repair of Renal Artery
Aneurysms
Zdenek Novak, Marc A. Passman, Thomas C. Matthews,
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Objectives: To compare renal function outcomes of
open repair, endovascular therapy and surveillance for renal
artery aneurysm (RAA).
Methods: Medical records of 40 patients with RAA
encountered between 2000 and 2012 were reviewed and
divided into 3 groups: endovascular therapy (ET, n ¼ 9),
open repair (OR; n ¼ 20), and surveillance (SV, n ¼ 11).
Creatinine level GFR estimates were based onMDRD equa-
tion. Nuclear studies were used to assess renal ﬂow/lateral-
ization. Hypertension (HTN) severity was assessed based
upon the number of medications used. SPSS package
(IBM) was used for statistical analysis.
Results: Demographics of all groups were similar. The
average size [mm] of RAA at the time of treatment was 19
6 6 for ET and 22 6 7.4 for OR. The average HTN meds
number before and after treatment for ET was 2.3 6 1.5
/ 3 6 1.8 and for OR: 1.7 6 1.1 / 1.7 6 0.9. HTNcontrol after intervention worsened in 33% of ET and
15% of OR patients and improved in 11.1% of ET and
20% of OR patients. The renal ﬂow was more frequently
lateralized (affected side ﬂow <45%) in the ET after the
procedure (20% (4/5) vs 50% (4/8) in OR). The average
GFR [mL/min/1.73m2] changed from 71.3 to 55.2 for
ET and from 82 to 81.4 for OR. No patient progressed
to dialysis during 1-10 years of surveillance. We also
observed signiﬁcant (P < .01) difference in hospital stay
(ET: 2.37 6 2.32 vs OR: 8.94 6 4.96 days). In the SV
group the average RAA size at presentation was 18 6
6.6 mm with no signiﬁcant growth over 2 to 66 months
of surveillance. The average GFR was 75.0 at presentation
and 79.7 at the latest visit. HTN control was similar with
2.4 6 1.9 meds at the beginning and 2.1 6 1.2 meds at
the latest visit. None of the SV patients crossed over to
treatment groups. RAA rupture was not observed.
Conclusions: Open repair of RAA tends to provides
better preservation of renal function than endovascular
treatment. While endovascular repair has less early
morbidity and shorter hospital stays, the reduced renal
preservation may have a negative impact on HTN control.
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Do Preoperative Statins Improve Outcomes After
Abdominal Aortic Aneurysm Repair?
Edgar L. Galiñanes1, Viktor Y. Dombrovskiy2, Shaun
Reynolds1, Todd R. Vogel1. 1Division of Vascular Surgery,
University of Missouri Hospital & Clinics, Columbia, Mo;
2UMDNJ, New Brunswick, NJ
Objectives: This study evaluated the utilization of
preoperative statins and their impact on perioperative
outcomes in patients undergoing open (OAR) or endovas-
cular (EVAR) aortic repair.
Methods: Patients $50 years of age with non-
ruptured AAA repair were identiﬁed in MedPAR ﬁles
2007-2008 utilizing ICD-9-CM codes. Preoperative sta-
tins use was identiﬁed using National Drug Codes in Part
D. c2 test, multivariable logistic regression, Kaplan-Meier
and Cox regression modeling was performed.
Results: 19,323 patients were identiﬁed undergoing
AAA repair (14,602 EVAR and 4721 OAR). 9,913
(50.3%) used statins before surgery. Bivariate analysis
demonstrated lower rates of hospital, 30-, 90-day and
1-year mortality in patients with statins compared to those
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Volume 57, Number 5S Abstracts 59Swithout after EVAR (1.0% vs 1.45%, P ¼ .01; 1.51% vs
2.3%, P ¼ .0004; 3.05% vs 4.66%, P < .0001; 7.91% vs
11.56%, P < .0001, respectively). Multivariable logistic
regression adjusting for age, gender, race, comorbidities
and procedure demonstrated preoperative statins use was
associated with a mortality reduction at 90-days postopera-
tively (OR, .80; 95% CI, 0.70-0.91; P ¼ .0014) and
1-year postoperatively (OR, .76; 95% CI, 0.69-0.84; P
¼ .0001).
Conclusions: Only half of patients undergoing AAA
repair had preoperative statins. After adjustment, statins
were not signiﬁcantly associated with a beneﬁt until 90
days after surgery suggesting greater long term mortality
beneﬁt. Further prospective studies are needed to assess
the beneﬁt of statins in the perioperative period.
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Using a Multimedia Presentation to Improve Patient
Understanding and Satisfaction With Informed
Consent for Minimally Invasive Vascular Procedures:
A Pilot Study
Nicolas Bowers1, Naomi Eisenberg2, Jeff Jaskolka3, Graham
Roche-Nagle2. 1Faculty of Medicine, University of
Toronto, Toronto, Ontario, Canada; 2Department of
Vascular Surgery, University Health Network, Toronto,
Ontario, Canada; 3Department of Interventional Radiology,
University Health Network, Toronto, Ontario, CanadaObjectives: Vascular interventions are becoming
increasingly complex; as procedures become more complex,
patient understanding of their treatments can become more
difﬁcult. This study aims to evaluate the utility of multimedia
presentations (MMP) on an Apple iPad computer for
patient understanding of vascular interventions.
Methods: Patients undergoing endovascular aneu-
rysm repair (EVAR), peripheral angioplasty, Hickman cath-
eter and peripherally inserted central catheter (PICC) line
insertion were randomized into a control group receiving
traditional verbal consent, or a MMP group that were
shown a 2 minute simpliﬁed video of their procedure in
addition to the traditional verbal consent. After obtaining
consent all patients completed a questionnaire assessing
comprehension of the procedure, and satisfaction with
the consent process.
Results: Eighty patients were recruited for this study,
twenty for each procedure. Patients reported the utility of
the MMP as an average of 4.8 on a 5 point Likert scale,
with 5 being ‘very helpful’ in understanding the procedure.
The MMP was shown to improve patient comprehension
of certain procedures, with angioplasty patients in the
MMP group answering more questions correctly during
assessment of comprehension (P ¼ .002).
Conclusions: This study has shown that patients ﬁnd
MMP during the consent process to be very helpful in
understanding vascular interventions, and that patients
receiving certain vascular interventions have improved
comprehension of their procedures when shown a MMP
during the consent process. Given the rapid rate of innova-
tion in vascular surgery, the use of MMP to help patients
understand new and complex procedures would be beneﬁ-
cial in the future care of patients undergoing vascular
interventions.
